Company intelligence / Profile preview

Ninurta

Visalia, California, USAninurta.com ↗
Ownership
Private
Development stage
Other
01

Overview

Ninurta has developed a noninvasive handheld medical device designed to screen for more than 65 common ailments—both physical and mental—within minutes. The technology is positioned as an accessible diagnostic tool that provides rapid results without invasive procedures. Clinical results or peer-reviewed studies are not detailed in public sources, but the product is described as tested and commercially available.

Therapeutic areas
Other
Modalities
Device
Industry
Physiological Monitoring
02

Partnerships

Not specified in public sources.

Beyond the preview

Go deeper on Ninurta.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ninurta.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call